| Glucose-6-phosphate dehydrogenase deficiency MD Cappellini, G Fiorelli The lancet 371 (9606), 64-74, 2008 | 1772 | 2008 |
| Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine C Borgna-Pignatti, S Rugolotto, P De Stefano, H Zhao, MD Cappellini, ... haematologica 89 (10), 1187-1193, 2004 | 1526 | 2004 |
| A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia MD Cappellini, A Cohen, A Piga, M Bejaoui, S Perrotta, L Agaoglu, ... Blood 107 (9), 3455-3462, 2006 | 932 | 2006 |
| Thalassaemia AT Taher, DJ Weatherall, MD Cappellini The Lancet 391 (10116), 155-167, 2018 | 715 | 2018 |
| Postgraduate haematology V Hoffbrand, DR Higgs, DM Keeling, AB Mehta John Wiley & Sons, 2016 | 703 | 2016 |
| Guidelines for the management of transfusion dependent thalassaemia (TDT) MD Cappellini, A Cohen, J Porter, A Taher, V Viprakasit Thalassaemia International Federation, 2014 | 658 | 2014 |
| Survival and complications in thalassemia C BORGNA‐PIGNATTI, MD Cappellini, P De Stefano, GC Del Vecchio, ... Annals of the New York Academy of Sciences 1054 (1), 40-47, 2005 | 556 | 2005 |
| Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major C Borgna-Pignatti, MD Cappellini, P De Stefano, GC Del Vecchio, ... Blood 107 (9), 3733-3737, 2006 | 506 | 2006 |
| Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management MD Cappellini, J Comin‐Colet, A de Francisco, A Dignass, W Doehner, ... American journal of hematology 92 (10), 1068-1078, 2017 | 477 | 2017 |
| Survival and disease complications in thalassemia major C BORGNA‐PIGNATTI, S Rugolotto, P De Stefano, A Piga, F Di Gregorio, ... Annals of the New York Academy of Sciences 850 (1), 227-231, 1998 | 471 | 1998 |
| Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia MD Cappellini, L Robbiolo, BM Bottasso, R Coppola, G Fiorelli, ... British journal of haematology 111 (2), 467-473, 2000 | 416 | 2000 |
| Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran A Taher, H Isma’eel, G Mehio, D Bignamini, A Kattamis, EA Rachmilewitz, ... Thrombosis and haemostasis 96 (10), 488-491, 2006 | 399 | 2006 |
| Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association S Fargion, A Piperno, MD Cappellini, M Sampietro, AL Fracanzani, ... Hepatology 16 (6), 1322-1326, 1992 | 391 | 1992 |
| Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study A Nobili, G Licata, F Salerno, L Pasina, M Tettamanti, C Franchi, ... European journal of clinical pharmacology 67, 507-519, 2011 | 387 | 2011 |
| Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel E Angelucci, S Matthes-Martin, D Baronciani, F Bernaudin, S Bonanomi, ... haematologica 99 (5), 811, 2014 | 381 | 2014 |
| Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with … A Piga, R Galanello, GL Forni, MD Cappellini, R Origa, A Zappu, ... haematologica 91 (7), 873-880, 2006 | 366 | 2006 |
| Outcomes of patients hospitalized with community-acquired, health care–associated, and hospital-acquired pneumonia M Venditti, M Falcone, S Corrao, G Licata, P Serra, ... Annals of internal medicine 150 (1), 19-26, 2009 | 358 | 2009 |
| Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias MD Cappellini, J Porter, A El-Beshlawy, CK Li, JF Seymour, M Elalfy, ... haematologica 95 (4), 557, 2010 | 342 | 2010 |
| A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease E Vichinsky, O Onyekwere, J Porter, P Swerdlow, J Eckman, P Lane, ... British journal of haematology 136 (3), 501-508, 2007 | 328 | 2007 |
| Hepatic iron concentration combined with long‐term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major PT Telfer, E Prestcott, S Holden, M Walker, AV Hoffbrand, B Wonke British journal of haematology 110 (4), 971-977, 2000 | 316 | 2000 |
Ali T. TaherProfessor of Medicine, Hematology & Oncology, American University of Beirut Medical CenterVerified email at aub.edu.lb
